1. Home
  2. UE vs ZLAB Comparison

UE vs ZLAB Comparison

Compare UE & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban Edge Properties of Beneficial Interest

UE

Urban Edge Properties of Beneficial Interest

N/A

Current Price

$20.59

Market Cap

2.6B

Sector

Finance

ML Signal

N/A

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$24.16

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UE
ZLAB
Founded
2014
2013
Country
United States
China
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
UE
ZLAB
Price
$20.59
$24.16
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$22.00
$49.60
AVG Volume (30 Days)
678.4K
1.0M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.91%
N/A
EPS Growth
23.33
38.46
EPS
0.18
N/A
Revenue
$471,935,000.00
$460,156,000.00
Revenue This Year
N/A
$9.75
Revenue Next Year
$4.12
$26.03
P/E Ratio
$115.72
N/A
Revenue Growth
6.06
15.33
52 Week Low
$18.46
$15.96
52 Week High
$24.11
$34.72

Technical Indicators

Market Signals
Indicator
UE
ZLAB
Relative Strength Index (RSI) 28.21 47.84
Support Level $20.53 $16.84
Resistance Level $22.10 $27.22
Average True Range (ATR) 0.27 0.81
MACD -0.03 -0.40
Stochastic Oscillator 1.86 16.06

Price Performance

Historical Comparison
UE
ZLAB

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: